Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $15.50, but opened at $14.53. Terumo shares last traded at $15.04, with a volume of 3,307 shares traded.

Wall Street Analyst Weigh In

Separately, Nomura upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.

Terumo Stock Performance

The stock has a market capitalization of $21.64 billion, a P/E ratio of 20.66 and a beta of 0.68. The company has a quick ratio of 0.97, a current ratio of 2.19 and a debt-to-equity ratio of 0.13. The company has a 50-day moving average price of $14.91 and a two-hundred day moving average price of $13.97.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings data on Friday, August 7th. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. The company had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.84 billion. Terumo had a net margin of 13.83% and a return on equity of 10.44%. Equities analysts expect that Terumo Corp. will post 0.7 earnings per share for the current year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.